Here, TGF-β induced TAZ expression through the Smad pathway in HepG2 liver cancer cells, modulating liver cancer progression by contributing to liver size control, regeneration, and oncogenesis (Ríos-López et al., 2023). Here, TGFB1 is linked to liver cancer.